Plasma galectin-3 (Gal-3) is elevated in, and drives, diverse inflammatory disorders, including cardiovascular diseases, diabetes, and cancer where it promotes tumor growth and metastasis. This study showed for the first time that two apheresis systems performing a procedure where blood is removed, separated, filtered and returned, were able to remove a modest amount of galectin-3.